News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,694 Results
Type
Article (1032)
Company Profile (2)
Press Release (21660)
Section
Business (11379)
Career Advice (68)
Deals (1359)
Drug Delivery (1)
Drug Development (1765)
FDA (329)
Job Trends (586)
News (14163)
Policy (572)
Tag
Academia (21)
Allergies (5)
Alliances (660)
ALS (1)
Alzheimer's disease (24)
Antibody-drug conjugate (ADC) (7)
Approvals (349)
Artificial intelligence (6)
Autoimmune disease (10)
Bankruptcy (4)
Best Places to Work (540)
Biosimilars (4)
Biotechnology (1)
Bladder cancer (7)
Brain cancer (1)
Breast cancer (16)
Cancer (160)
Cardiovascular disease (14)
Career advice (51)
Career pathing (3)
CAR-T (3)
Cell therapy (11)
Cervical cancer (3)
Clinical research (1713)
Collaboration (13)
Compensation (15)
Complete response letters (1)
COVID-19 (29)
CRISPR (4)
C-suite (2)
Cystic fibrosis (3)
Data (238)
Depression (2)
Dermatology (2)
Diabetes (14)
Diagnostics (205)
Digital health (2)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (3)
Earnings (11314)
Events (2201)
Executive appointments (1)
FDA (502)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (17)
Gene editing (7)
Gene therapy (11)
GLP-1 (20)
Government (49)
Guidances (123)
Healthcare (516)
HIV (1)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (10)
Indications (7)
Infectious disease (37)
Inflammatory bowel disease (3)
Influenza (4)
Intellectual property (5)
Interviews (14)
IPO (1026)
IRA (1)
Job creations (86)
Job search strategy (42)
JPM (1)
Kidney cancer (2)
Labor market (5)
Layoffs (10)
Legal (108)
Lung cancer (37)
Lymphoma (14)
Manufacturing (14)
MASH (7)
Medical device (542)
Medtech (546)
Mergers & acquisitions (338)
Metabolic disorders (33)
mRNA (1)
Multiple sclerosis (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (4)
Neuroscience (57)
Neurotech (1)
NextGen: Class of 2026 (130)
Non-profit (42)
Obesity (12)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (3)
Parkinson's disease (2)
Partnered (1)
Patents (3)
Patient recruitment (6)
Peanut (1)
People (612)
Phase 1 (379)
Phase 2 (610)
Phase 3 (823)
Pipeline (669)
Policy (1)
Postmarket research (61)
Preclinical (134)
Prostate cancer (5)
Radiopharmaceuticals (10)
Rare diseases (17)
Real estate (93)
Regulatory (489)
Reports (9)
Research institute (23)
Resumes & cover letters (11)
Rett syndrome (1)
RSV (4)
Schizophrenia (13)
Series A (1)
Series B (3)
Sickle cell disease (3)
Special edition (4)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (53)
Supply chain (2)
Vaccines (12)
Venture capital (1)
Weight loss (7)
Women's health (4)
Worklife (1)
Date
Last 7 days (26)
Last 30 days (121)
Last 365 days (1263)
2026 (337)
2025 (1233)
2024 (1439)
2023 (1680)
2022 (1806)
2021 (1788)
2020 (1535)
2019 (1012)
2018 (914)
2017 (621)
2016 (339)
2015 (6567)
2014 (446)
2013 (239)
2012 (269)
2011 (344)
2010 (302)
Location
Africa (35)
Alabama (1)
Arizona (8)
Asia (1413)
Australia (163)
California (470)
Canada (143)
China (32)
Colorado (23)
Connecticut (44)
Delaware (16)
Europe (3049)
Florida (75)
Georgia (15)
Illinois (28)
India (1)
Indiana (43)
Japan (12)
Kansas (1)
Kentucky (3)
Louisiana (4)
Maine (5)
Maryland (56)
Massachusetts (323)
Michigan (17)
Minnesota (29)
Missouri (7)
Montana (1)
Nevada (5)
New Hampshire (3)
New Jersey (196)
New York (125)
North Carolina (78)
Northern California (260)
Ohio (13)
Oklahoma (1)
Pennsylvania (107)
South America (51)
Southern California (177)
Tennessee (5)
Texas (71)
United States (1807)
Utah (14)
Virginia (5)
Washington State (40)
Wisconsin (7)
22,694 Results for "153".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Aluna Raises $15.3M in Series B Funding To Empower Asthma, COPD and Cystic Fibrosis Patients and Their Doctors
Aluna, the award-winning lung health management platform, announced it has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD.
January 31, 2023
·
4 min read
Biotech Beach
Regard Raises $15.3 Million Series A to Accurately and Quickly Uncover Patient Diagnoses
Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, today announced it has raised $15.3 million in Series A funding.
June 29, 2022
·
4 min read
Stool Softener Market Size to Reach USD 1.53 Billion in 2027 | Emergen Research
The global stool softener market size was USD 1.53 Billion in 2021 and is expected to register a revenue CAGR of 7.15% during the forecast period, according to latest analysis by Emergen Research.
June 27, 2022
·
7 min read
Healthcare ERP Market Size to Worth Around US$ 15.3 Bn by 2030
According to Vision Research Reports, the global Healthcare ERP Market size is expected to worth around US$ 15.3 billion by 2030 and is projected to grow at a CAGR of 8.6% during forecast period 2021 to 2030.
May 31, 2022
·
6 min read
Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023
Kuros Biosciences, a leader in next-generation bone graft technologies, announced financial results for full year 2023 along with continued significant growth.
March 13, 2024
·
10 min read
Deals
Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction
Meridian Bioscience, Inc and SD Biosensor, Inc. (“SDB”) (KOSE: A137310) and SJL Partners LLC (“SJL”) (collectively, the “Consortium”) announced today that they have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the Consortium will acquire Meridian in an all-cash transaction valued at approximately $1.53 billion.
July 7, 2022
·
13 min read
Policy
NIIMBL Receives $153M in Awards from NIST
Tthe National Institute for Innovation in Manufacturing Biopharmaceuticals confirms that it has received $153M in new funding from the National Institute of Standards and Technology as announced by U.S. Commerce Secretary Gina Raimondo at NIIMBL’s National Meeting in Washington, DC.
July 14, 2021
·
3 min read
Biotech Bay
Evidation Raises $153M to Scale Virtual Health Capabilities of Achievement™ Platform
Evidation Health today announced the close of $153 million in Series E growth funding to rapidly expand its virtual health programs on AchievementTM, the largest digital health network in the United States.
March 22, 2021
·
4 min read
Track and Trace Solutions Market to reach US$ 6,049.0 Mn by 2027 with a CAGR of 15.3%
The Track and Trace Solutions market was valued at US$ 1,728.3 million in 2018 and it is projected to reach US$ 6,049.0 million by 2027; it is expected to grow at a CAGR of 15.3% from 2018 to 2027.
July 21, 2021
·
5 min read
Deals
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM is a United States (U.S.) based company developing therapeutic radiopharmaceuticals for primary and metastatic bone cancer.
February 7, 2024
·
9 min read
Previous
2 of 2,270
Next